businesspress24.com - Functional Technologies Appoints Interim CFO
 

Functional Technologies Appoints Interim CFO

ID: 1070979

(firmenpresse) - VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 01/09/12 -- Functional Technologies Corp. (TSX VENTURE: FEB) (the "Company") announced it has appointed Mr. Christopher Morris as interim Chief Financial Officer (CFO) to replace Ms. Sherrill Palmer, who has departed the Company. The Board of Directors wishes Ms. Palmer well in her future endeavors.

Mr. Morris has more than 12 years of experience in the finance industry including senior roles in corporate finance, capital markets, and restructuring initiatives. Mr. Morris is founder and President of R.C. Morris & Company, which provides various financial, advisory and consulting services to companies, investors and executives, and has previously held several senior executive roles in both private and public companies. Mr. Morris holds a PhD from Cambridge University.

About Functional Technologies Corp.

Functional Technologies develops and commercializes proprietary, advanced yeast-based solutions to significant challenges in the food, beverage and healthcare industries. The Company's platform improves the performance of innate yeast functions, and prevents the formation of naturally occurring toxins and contaminants that either affect final product quality or are classified by the World Health Organization as probable human carcinogens. Functional Technologies' lead technologies include yeasts that prevent and reduce the formation of the foul-smelling hydrogen sulphide (H2S) and the carcinogens acrylamide and ethyl carbamate (more commonly known as urethane), by-products of food and beverage processing. These contaminants are found in many commonly consumed items, such as fermented food products and alcoholic beverages, and baked and fried foods. With a head office in Vancouver, Functional Technologies Corp. has R&D operations in Prince Edward Island and Europe, as well as a U.S. sales office in Napa Valley, California. For more information, please visit our website at .

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.







Contacts:
Functional Technologies Corp.
Connie Chen, PhD
VP, Corporate Development and Communications
+1.647.282.5038


Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  Functional Technologies Engages Momentum Public Relations for Investor Relations
Marina Biotech, Inc. Provides Update on Its Broad Nucleic Acid-Based Drug Discovery Platform and 2012 Goals
Bereitgestellt von Benutzer: MARKETWIRE
Datum: 09.01.2012 - 08:15 Uhr
Sprache: Deutsch
News-ID 1070979
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

VANCOUVER, BRITISH COLUMBIA


Phone:

Kategorie:

Biotech


Anmerkungen:


Diese Pressemitteilung wurde bisher 109 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Functional Technologies Appoints Interim CFO
"
steht unter der journalistisch-redaktionellen Verantwortung von

Functional Technologies Corp. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Functional Technologies Corp.



 

Who is online

All members: 10 568
Register today: 1
Register yesterday: 2
Members online: 0
Guests online: 76


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.